Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
Lapatinib Combined With Letrozole Versus Letrozole and Placebo As First-Line Therapy for Postmenopausal Hormone Receptor–Positive Metastatic Breast CancerStephen Johnston ; John Pippen, Jr ; Xavier Pivot ; Mikhail Lichinitser ; Saeed Sadeghi ; Veronique Dieras ; Henry Leonidas Gomez ; Gilles Romieu ; Alexey Manikhas ; M. John Kennedy ; Michael F. Press ; Julie Maltzman ; Allison Florance ; Lisa O'Rourke ; Cristina Oliva ; Steven Stein ; Mark PegramJournal of clinical oncology, 2009-11, Vol.27 (33), p.5538-5546 [Periódico revisado por pares]Alexandria, VA: American Society of Clinical OncologyTexto completo disponível |
|
2 |
Material Type: Artigo
|
Phase III, Double-Blind, Randomized Study Comparing Lapatinib Plus Paclitaxel With Placebo Plus Paclitaxel As First-Line Treatment for Metastatic Breast CancerDI LEO, Angelo ; GOMEZ, Henry L ; WILLIAMS, Lisa S ; DERING, Judy ; FINN, Richard S ; PRESS, Michael F ; AZIZ, Zeba ; ZVIRBULE, Zanete ; BINES, Jose ; ARBUSHITES, Michael C ; GUERRERA, Stephanie F ; KOEHLER, Maria ; OLIVA, Cristina ; STEIN, Steven HJournal of clinical oncology, 2008-12, Vol.26 (34), p.5544-5552 [Periódico revisado por pares]Alexandria, VA: American Society of Clinical OncologyTexto completo disponível |
|
3 |
Material Type: Artigo
|
Impact of Breast Cancer Subtypes and Treatment on Survival: An Analysis Spanning Two DecadesHAQUE, Reina ; AHMED, Syed A ; INZHAKOVA, Galina ; JIAXIAO SHI ; AVILA, Chantal ; POLIKOFF, Jonathan ; BERNSTEIN, Leslie ; ENGER, Shelleym ; PRESS, Michael FCancer epidemiology, biomarkers & prevention, 2012-10, Vol.21 (10), p.1848-1855 [Periódico revisado por pares]Philadelphia, PA: American Association for Cancer ResearchTexto completo disponível |
|
4 |
Material Type: Artigo
|
Risk factors by molecular subtypes of breast cancer across a population-based study of women 56 years or youngerGaudet, Mia M. ; Press, Michael F. ; Haile, Robert W. ; Lynch, Charles F. ; Glaser, Sally L. ; Schildkraut, Joellen ; Gammon, Marilie D. ; Douglas Thompson, W. ; Bernstein, Jonine L.Breast cancer research and treatment, 2011-11, Vol.130 (2), p.587-597 [Periódico revisado por pares]Boston: Springer USTexto completo disponível |
|
5 |
Material Type: Artigo
|
Results of Two Open-Label, Multicenter Phase II Studies of Docetaxel, Platinum Salts, and Trastuzumab in HER2-Positive Advanced Breast CancerPegram, Mark D. ; Pienkowski, Tadeusz ; Northfelt, Donald W. ; Eiermann, Wolfgang ; Patel, Ravi ; Fumoleau, Pierre ; Quan, Eleonor ; Crown, John ; Toppmeyer, Deborah ; Smylie, Michael ; Riva, Alessandro ; Blitz, Sandra ; Press, Michael F. ; Reese, David ; Lindsay, Mary-Ann ; Slamon, Dennis J.JNCI : Journal of the National Cancer Institute, 2004-05, Vol.96 (10), p.759-769 [Periódico revisado por pares]Cary, NC: Oxford University PressTexto completo disponível |
|
6 |
Material Type: Artigo
|
Alteration of Topoisomerase II–Alpha Gene in Human Breast Cancer: Association With Responsiveness to Anthracycline-Based ChemotherapyPRESS, Michael F ; SAUTER, Guido ; ROBERT, Nicholas ; CROWN, John ; BEE, Valerie ; TAUPIN, Henry ; FLOM, Kerry J ; TABAH-FISCH, Isabelle ; PAULETTI, Giovanni ; LINDSAY, Mary-Ann ; RIVA, Alessandro ; SLAMON, Dennis J ; BUYSE, Marc ; BERNSTEIN, Leslie ; GUZMAN, Roberta ; SANTIAGO, Angela ; VILLALOBOS, Ivonne E ; EIERMANN, Wolfgang ; PIENKOWSKI, Tadeusz ; MARTIN, MiguelJournal of clinical oncology, 2011-03, Vol.29 (7), p.859-867 [Periódico revisado por pares]Alexandria, VA: American Society of Clinical OncologyTexto completo disponível |
|
7 |
Material Type: Artigo
|
Assessment of HER2 gene amplification in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116/SWOG9008 clinical trialGordon, M.A. ; Gundacker, H.M. ; Benedetti, J. ; Macdonald, J.S. ; Baranda, J.C. ; Levin, W.J. ; Blanke, C.D. ; Elatre, W. ; Weng, P. ; Zhou, J.Y. ; Lenz, H.J. ; Press, M.F.Annals of oncology, 2013-07, Vol.24 (7), p.1754-1761 [Periódico revisado por pares]Oxford: Elsevier LtdTexto completo disponível |
|
8 |
Material Type: Artigo
|
Body mass index at age 18 years and recent body mass index in relation to risk of breast cancer overall and ER/PR/HER2-defined subtypes in white women and African-American women: a pooled analysisMa, Huiyan ; Ursin, Giske ; Xu, Xinxin ; Lee, Eunjung ; Togawa, Kayo ; Malone, Kathleen E ; Marchbanks, Polly A ; McDonald, Jill A ; Simon, Michael S ; Folger, Suzanne G ; Lu, Yani ; Sullivan-Halley, Jane ; Deapen, Dennis M ; Press, Michael F ; Bernstein, LeslieBreast cancer research : BCR, 2018-01, Vol.20 (1), p.5-14, Article 5 [Periódico revisado por pares]England: BioMed Central LtdTexto completo disponível |
|
9 |
Material Type: Artigo
|
Immunohistochemistry and fluorescence in situ hybridization assessment of HER2 in clinical trials of adjuvant therapy for breast cancer (NCCTG N9831, BCIRG 006, and BCIRG 005)Perez, Edith A. ; Press, Michael F. ; Dueck, Amylou C. ; Jenkins, Robert B. ; Kim, Chungyeul ; Chen, Beiyun ; Villalobos, Ivonne ; Paik, Soonmyung ; Buyse, Marc ; Wiktor, Anne E. ; Meyer, Reid ; Finnigan, Melanie ; Zujewski, JoAnne ; Shing, Mona ; Stern, Howard M. ; Lingle, Wilma L. ; Reinholz, Monica M. ; Slamon, Dennis J.Breast cancer research and treatment, 2013-02, Vol.138 (1), p.99-108 [Periódico revisado por pares]Boston: Springer USTexto completo disponível |
|
10 |
Material Type: Artigo
|
HER2 Status in Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma for Entry to the TRIO-013/LOGiC Trial of LapatinibPress, Michael F ; Ellis, Catherine E ; Gagnon, Robert C ; Grob, Tobias J ; Buyse, Marc ; Villalobos, Ivonne ; Liang, Zhiyong ; Wu, Shafei ; Bang, Yung-Jue ; Qin, Shu-Kui ; Chung, Hyun Cheol ; Xu, Jianming ; Park, Joon Oh ; Jeziorski, Krzysztof ; Afenjar, Karen ; Ma, Yanling ; Estrada, Monica C ; Robinson, Douglas M ; Scherer, Stefan J ; Sauter, Guido ; Hecht, J Randolph ; Slamon, Dennis JMolecular cancer therapeutics, 2017-01, Vol.16 (1), p.228-238 [Periódico revisado por pares]United States: American Association for Cancer Research IncTexto completo disponível |